Physician profile
Abigail E Davis
NPI 1588913958
$2,156.84
in general payments reported to CMS, 2019-2025
26 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $474 · 2023: $387 · 2024: $403 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.08 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.55 | 2021-2023 | |
| Astellas Pharma US INC | $209.26 | 2023-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $164.10 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $163.00 | 2021-2025 | Slynd |
| Evofem Biosciences, INC. | $152.84 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $139.71 | 2021-2022 | |
| Organon LLC | $131.14 | 2021-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $102.85 | 2021-2023 | |
| Exact Sciences Corporation | $88.65 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $69.06 | 2021-2022 | |
| Pfizer INC. | $67.80 | 2021-2023 | |
| Dexcom, INC. | $65.95 | 2024-2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $63.26 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $58.97 | 2021-2024 | Gardasil 9, Gardasil |
| Heron Therapeutics, INC. | $54.67 | 2022-2023 | Zynrelef |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $53.92 | 2022 | |
| Supernus Pharmaceuticals, INC. | $48.88 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $48.88 | 2025 | Zurzuvae |
| Convatec INC. | $46.12 | 2023-2024 | |
| Optumhealth Care Solutions, LLC | $41.96 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $40.88 | 2021-2024 | Injectafer |
| Novo Nordisk INC | $31.87 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $21.88 | 2023 | Seglentis |
| Smith+Nephew, INC. | $21.17 | 2022 | |
| Aspira Women'S Health INC | $16.86 | 2024 | Ova1 |
| Alexion Pharmaceuticals, INC. | $15.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.